Within the intricate realm of cardiovascular health, the blueprint of our genes exerts a profound influence on the fate of our hearts. Inherited cardiomyopathies, a diverse group of conditions with a strong genetic basis, offer us a unique glimpse into the intricate interplay between our DNA and the intricate machinery of the heart. This comprehensive […]
Women, Heart Disease, and the Need for Better Research
Heart disease is a leading cause of death in women, yet it is often thought of as a predominantly male disease. In fact, heart disease affects women just as much as men, and in some cases, even more so. Historically, clinical trials for heart disease have overwhelmingly enrolled men, and the results have been applied […]
Targeting Diabetes to Protect Your Heart: A Comprehensive Plan
Type 2 diabetes mellitus or adult-onset diabetes is a chronic disease characterized by high levels of blood sugar, usually >126 mg/dL or a Hb A1c >6.5. This is the result of the body becoming resistant to insulin and cannot use insulin properly. Diabetes mellitus is heavily influenced by dietary patterns, physical activity, and body weight. […]
Women and Heart Disease
Heart disease is a leading cause of death in women, and its incidence is three times as high as breast cancer. Despite this, there is often a lack of awareness of the risk of heart disease in women, leading to underdiagnosis and undertreatment. There are female-specific conditions that increase the risk of heart diseases present […]
HYPERTENSION, THE SILENT KILLER
This article was written in collaboration with Dr. Suzanne Oparil, M.D. Distinguished Professor of Medicine. Professor of Cell, Developmental and Integrative Biology. Director, Vascular Biology and Hypertension Program. Section Chief of Vascular Biology and Hypertension, at the University of Alabama at Birmingham. HYPERTENSION, THE SILENT KILLER Hypertension is a pervasive problem and affects nearly 50% of […]
THE HDL CHOLESTEROL CONUNDRUM
THE HDL CHOLESTEROL CONUNDRUM The role of High-density lipoprotein (HDL) cholesterol in the development of atherosclerosis and cardiovascular (CV) morbidity and mortality has long been recognized. Epidemiological studies have demonstrated an inverse relationship between HDL cholesterol and CV events. HDL is incorporated in the calculation of the 10-yr ASCVD risk in patients who have never […]
NON-STATIN TREATMENT FOR CHOLESTEROL
This article was written in collaboration with Dr. John J.P. Kastelein, M.D., Ph.D., FESC.Professor of Medicine, University of Amsterdam. NON-STATIN THERAPIES FOR LDL CHOLESTEROL LOWERING The role of statin in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD) has been well demonstrated to lower major cardiovascular events. It is the number one recommendation by […]
LIPOPROTEIN (a), A BIOMARKER FOR STROKE
This article was written in collaboration with Dr. Leslie Cho, MD.Director of the Cleveland Clinic’s Women’s Cardiovascular Center. Lp (a) OR LIPOPROTEIN (a), A BIOMARKER FOR HEART DISEASE AND STROKE Cardiovascular disease remains the leading cause of death and disability worldwide. Despite advances in lipid management, there remain significant risks of heart disease and stroke […]
IN “REGARDS” TO THE STROKE BELT.
This article was written in collaboration with Dr. George Howard, Distinguished Professor in the department of Biostatistics, retired from the UAB School of Public Health.
STATIN VS SUPPLEMENTS FOR HIGH CHOLESTEROL
This article was written in collaboration with Dr. Steven Nissen, MD.Chief Academic Officer of the Heart and Vascular Institute at the Cleveland Clinic and Professor of Medicine at the Lerner College of Medicine. With the high prevalence of risk factors and cardiovascular disease in the US, looking at Statin vs Supplements for high cholesterol appears […]
- 1
- 2
- 3
- …
- 12
- Next Page »